A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.

Documenti analoghi

• A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study.
  di: Wu, Ming-Tsang, et al.
  Pubblicazione: (2003)
• The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study.
  di: Hu, H, et al.
  Pubblicazione: (2001)
• Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes.
  di: Schwartz, B S, et al.
  Pubblicazione: (2000)
• The in vitro effect of zinc on the inhibition of human delta-aminolevulinic acid dehydratase by lead.
  di: Border, E A, et al.
  Pubblicazione: (1976)
• delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
  di: Schwartz, B S, et al.
  Pubblicazione: (1997)